Aligos Therapeutics, Inc. — EFFECT Filings
6 EFFECT filings on record
This page lists all EFFECT filings submitted to the SEC by Aligos Therapeutics, Inc. (ALGS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aligos Therapeutics, Inc. has filed 6 EFFECT documents with the SEC since 2020. To view all SEC filings by Aligos Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
3
4
424B3
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| EFFECT | — | 9999999995-25-000975 | Apr 3, 2025 | — |
| EFFECT | — | 9999999995-24-003508 | Nov 18, 2024 | — |
| EFFECT | — | 9999999995-23-003451 | Nov 27, 2023 | — |
| EFFECT | — | 9999999995-21-004423 | Nov 19, 2021 | — |
| EFFECT | — | 9999999995-21-002615 | Jun 30, 2021 | — |
| EFFECT | — | 9999999995-20-002863 | Oct 15, 2020 | — |